Article
Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma.
Scientific reports - 25 Feb 2022
Naidoo Michael, Jones Leanne, Conboy Benjamin, Hamarneh Wael, D'Souza Darwin, Anthony Karen, Machado Lee R
Abstract excerpt
Alterations in the expression of the Duchenne muscular dystrophy (DMD) gene have been associated with the development, progression and survival outcomes of numerous cancers including tumours of the central nervous system. We undertook a detailed bioinformatic analysis of low-grade glioma (LGG) bulk RNAseq data to characterise the association between DMD expression and LGG survival outcomes. High DMD expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
